Martin Boyer, Philippe De Donder, Claude Fluet, Marie-Louise Leroux, and Pierre-Carl Michaud, “Long-Term Care Insurance: Information Frictions and Selection”, TSE Working Paper, n. 19-1034, September 2019.
David Bardey, and Philippe De Donder, “A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention”, TSE Working Paper, n. 19-1035, September 2019, revised January 22, 2024.
Pierre Dubois, and Morten Saethre, “On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector”, TSE Working Paper, n. 18-883, January 2018, revised March 2020.
Pierre Dubois, Rachel Griffith, and Martin O'Connell, “How well targeted are soda taxes?”, TSE Working Paper, n. 17-868, December 2017, revised March 2020.
Pierre Dubois, and Margaret Kyle, “The Effects of Pharmaceutical Innovation on Cancer Mortality Rates”, TSE Working Paper, n. 16-688, September 2016.
David Bardey, Sanxi Li, and Yaping Wu, “Health Care Insurance Payment Policy when the Physician and Patient May Collude”, TSE Working Paper, n. 15-572, May 2015.
David Bardey, Helmuth Cremer, and Jean-Marie Lozachmeur, “The design of insurance coverage for medical products under imperfect competition”, TSE Working Paper, n. 15-553, January 2015.
Pierre Dubois, and Laura Lasio, “Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals”, TSE Working Paper, n. 14-471, February 2014, revised March 2018.